BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10961027)

  • 1. Oxidant stress mechanisms in heart failure.
    Chandra M; Surendra K; Kapoor RK; Ghatak A; Kaur G; Pandey NR; Misra MK
    Boll Chim Farm; 2000; 139(3):149-52. PubMed ID: 10961027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention.
    Korantzopoulos P; Galaris D; Papaioannides D; Siogas K
    Med Sci Monit; 2003 Jun; 9(6):RA120-5. PubMed ID: 12824962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate-thiol interaction.
    Parodi O; De Maria R; Roubina E
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):765-74. PubMed ID: 17885513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-induced leaky sarcoplasmic reticulum underlying acute heart failure in severe burn trauma.
    Deng J; Wang G; Huang Q; Yan Y; Li K; Tan W; Jin C; Wang Y; Liu J
    Free Radic Biol Med; 2008 Feb; 44(3):375-85. PubMed ID: 17976387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.
    Bergamini C; Cicoira M; Rossi A; Vassanelli C
    Eur J Heart Fail; 2009 May; 11(5):444-52. PubMed ID: 19346534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidative stress and endothelial dysfunction in heart failure].
    Devaux C; Varin R; Mulder P; Richard V; Thuillez C
    Therapie; 2001; 56(5):575-81. PubMed ID: 11806296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant treatment for heart failure: friend or foe?
    Thomson MJ; Frenneaux MP; Kaski JC
    QJM; 2009 May; 102(5):305-10. PubMed ID: 19095676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
    van Empel VP; Bertrand AT; van Oort RJ; van der Nagel R; Engelen M; van Rijen HV; Doevendans PA; Crijns HJ; Ackerman SL; Sluiter W; De Windt LJ
    J Am Coll Cardiol; 2006 Aug; 48(4):824-32. PubMed ID: 16904556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
    Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
    Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
    Qin F; Simeone M; Patel R
    Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.
    Amado LC; Saliaris AP; Raju SV; Lehrke S; St John M; Xie J; Stewart G; Fitton T; Minhas KM; Brawn J; Hare JM
    J Mol Cell Cardiol; 2005 Sep; 39(3):531-6. PubMed ID: 15963530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and heart failure: oxidative stress and energetic metabolism in rats.
    Seiva FR; Ebaid GM; Castro AV; Okoshi K; Nascimento A; Rocha KK; Padovani CR; Cicogna AC; Novelli EL
    Growth Horm IGF Res; 2008 Aug; 18(4):275-83. PubMed ID: 18191600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
    Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
    Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced sarcoplasmic reticulum Ca2+ uptake and increased Na+-Ca2+ exchanger expression in left ventricle myocardium of dogs with progression of heart failure.
    Mishra S; Sabbah HN; Rastogi S; Imai M; Gupta RC
    Heart Vessels; 2005 Feb; 20(1):23-32. PubMed ID: 15700199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
    Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
    Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure--new insights.
    Blum A
    Isr Med Assoc J; 2009 Feb; 11(2):105-11. PubMed ID: 19432040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of coenzyme Q10 in heart failure.
    Weant KA; Smith KM
    Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure.
    Kupper N; Gidron Y; Winter J; Denollet J
    Psychosom Med; 2009 Nov; 71(9):973-80. PubMed ID: 19834046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmias following exposure of failing hearts to oxidative stress in vitro.
    Brigadeau F; Gelé P; Marquié C; Soudan B; Lacroix D
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):629-36. PubMed ID: 15946363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.